Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01921569 · ClinicalTrials.gov registry record · NA
Micronized Dehydrated Human Amniotic Membrane Suspension in the Treatment of Lateral Epicondylitis
A NA study, sponsored by MiMedx Group.
- Terminated
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT01921569 is a NA study that was terminated before completion, run by MiMedx Group. The registered enrollment target is 5 participants.
The verdict
NCT01921569, a NA study, was terminated before completion, sponsored by MiMedx Group.
- TERMINATED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether micronized dehydrated human amniotic membrane (dHACM) suspension is more effective in reducing inflammation than conservative measures alone when used to treat acute/early lateral epicondylitis.
Interventions
- BEHAVIORAL Standard of Care Therapy
- OTHER dHACM Injection
- OTHER Normal Saline Injection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2013-06 |
| Est. Completion | 2014-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01921569
The ClinicalTrials.gov registry entry for NCT01921569 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is MiMedx Group, which has 32 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Standard of Care Therapy is the first listed.
NCT01921569 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01921569 about?
NCT01921569 is a clinical study titled "Micronized Dehydrated Human Amniotic Membrane Suspension in the Treatment of Lateral Epicondylitis". The purpose of this study is to determine whether micronized dehydrated human amniotic membrane (dHACM) suspension is more effective in reducing inflammation than conservative measures alone when used to treat acute/early lateral epicondylitis.
What is the current status of trial NCT01921569?
This trial is currently terminated. It is a NA study. The enrollment target is 5 participants. The study started on 2013-06. Estimated completion is 2014-03.
What interventions are being tested in trial NCT01921569?
The interventions under investigation include: Standard of Care Therapy (BEHAVIORAL), dHACM Injection (OTHER), Normal Saline Injection (OTHER).
Who is sponsoring clinical trial NCT01921569?
This trial is sponsored by MiMedx Group, which has 32 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.